Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry

BACKGROUND: Prospectively collected, routine clinical practice-based data on antithrombotic therapy in non-valvular atrial fibrillation (AF) patients are important for assessing real-world comparative outcomes. The objective was to compare the safety and effectiveness of dabigatran versus vitamin K...

Descripción completa

Detalles Bibliográficos
Autores principales: Huisman, Menno V., Teutsch, Christine, Lu, Shihai, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Ma, Chang-Sheng, Rothman, Kenneth J., Lohmann, Ragna, Gurusamy, Venkatesh Kumar, Bartels, Dorothee B., Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054866/
https://www.ncbi.nlm.nih.gov/pubmed/35294623
http://dx.doi.org/10.1007/s00392-021-01957-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054866/
https://www.ncbi.nlm.nih.gov/pubmed/35294623
http://dx.doi.org/10.1007/s00392-021-01957-1

Ejemplares similares